|
Originally published In Press as doi:10.1074/jbc.M009355200 on November 29, 2000
J. Biol. Chem., Vol. 276, Issue 9, 6797-6806, March 2, 2001
Altered Regulation of Cell Cycle Machinery Involved in
Interleukin-1-induced G1 and G2 Phase Growth
Arrest of A375S2 Human Melanoma Cells*
Toshimi
Murai ,
Yukari
Nakagawa,
Hideko
Maeda, and
Kinuko
Terada
From the Department of Biological Evaluation, National Institute of
Health Sciences, Osaka Branch, Hoenzaka 1-1-43, Chuo-ku,
Osaka 540-0006, Japan
Interleukin-1 (IL-1) inhibits the growth of
A375S2 human melanoma cells by arresting them at G1
and G2 phases of the cell cycle. The arrests are preceded
by a rapid decrease in kinase activities of cyclin E-Cdk2 and cyclin
B1-Cdc2, which are critical for G1-S and G2-M
progression, respectively. IL-1 quickly enhances the protein expression
of the CDK inhibitor p21cip1. The induced p21 binds
preferentially to cyclin E-Cdk2, and the increase in p21 binding
parallels the decrease in cyclin E-Cdk2 activity. Thus, p21 is likely
to be responsible for the inhibition of cyclin E-Cdk2 activity and
G1 arrest. Coinciding with the decrease in cyclin B1-Cdc2
activity, there is an increase in tyrosine phosphorylation of Cdc2,
suggesting that an increase in the inactive Tyr-15-phosphorylated form
of Cdc2 is involved in the decrease in cyclin B1-Cdc2 activity and
G2 arrest. Furthermore, we found that IL-1 causes rapid
dephosphorylation of p107, but not of pRb or p130, while the total
protein levels of p130 are increased. Thus, IL-1 may exert its
growth-arresting effects via p107 and p130 pathways rather than through
pRb.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence and reprint requests should be addressed:
National Institute of Health Sciences, Osaka Branch, Div. of Biological
Evaluation, Hoenzaka 1-1-43, Chuo-ku, Osaka 540-0006, Japan. Tel.:
81-6-6941-1533; Fax: 81-6-6942-0716; E-mail: murai@nihs.go.jp.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. H. Shen, S. T. Jackson, S. R. Broussard, R. H. McCusker, K. Strle, G. G. Freund, R. W. Johnson, R. Dantzer, and K. W. Kelley
IL-1{beta} Suppresses Prolonged Akt Activation and Expression of E2F-1 and Cyclin A in Breast Cancer Cells
J. Immunol.,
June 15, 2004;
172(12):
7272 - 7281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Dewberry, D. C. Crossman, and S. E. Francis
Interleukin-1 Receptor Antagonist (IL-1RN) Genotype Modulates the Replicative Capacity of Human Endothelial Cells
Circ. Res.,
June 27, 2003;
92(12):
1285 - 1287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-y. Huang, Y. Wu, N. Hedrick, and D. H. Gutmann
T-Cadherin-Mediated Cell Growth Regulation Involves G2 Phase Arrest and Requires p21CIP1/WAF1 Expression
Mol. Cell. Biol.,
January 15, 2003;
23(2):
566 - 578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Nathe, J. Deou, B. Walsh, B. Bourns, A. W. Clowes, and G. Daum
Interleukin-1{beta} Inhibits Expression of p21(WAF1/CIP1) and p27(KIP1) and Enhances Proliferation in Response to Platelet-Derived Growth Factor-BB in Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2002;
22(8):
1293 - 1298.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|